All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10360784" target="_blank" >RIV/00216208:11110/17:10360784 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/17:10360784

  • Result on the web

    <a href="http://dx.doi.org/10.1194/jlr.M072751" target="_blank" >http://dx.doi.org/10.1194/jlr.M072751</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1194/jlr.M072751" target="_blank" >10.1194/jlr.M072751</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Serum lipid profile changes predict neurodegeneration in interferon-beta 1a-treated multiple sclerosis patients

  • Original language description

    The purpose of this work was to determine whether changes in cholesterol profiles after interferon- (IFN-)1a treatment initiation following the first demyelinating event suggestive of multiple sclerosis are associated with clinical and MRI outcomes over 4 years. A group of 131 patients (age: 27.9 +/- 7.8 years, 63% female) with serial 3-monthly clinical and 12-monthly MRI follow-ups over 4 years were investigated. Serum cholesterol profiles, including total cholesterol (TC), HDL cholesterol (HDL-C), and LDL cholesterol (LDL-C) were obtained at baseline, 1 month, 3 months, and every 6 months thereafter. IFN-1a initiation caused rapid decreases in serum HDL-C, LDL-C, and TC within 1 month of IFN-1a initiation (all P &lt; 0.001) that returned slowly toward baseline. In predictive mixed model analyses, greater percent decreases in HDL-C after 3 months of IFN-1a treatment initiation were associated with less brain atrophy over the 4 year time course, as assessed by percent brain volume change (P &lt; 0.001), percent gray matter volume change (P &lt; 0.001), and percent lateral ventricle volume change (P = 0.005). Decreases in cholesterol biomarkers following IFN-1a treatment are associated with brain atrophy outcomes over 4 years. Pharmacological interventions targeting lipid homeostasis may be clinically beneficial for disrupting neurodegenerative processes.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30103 - Neurosciences (including psychophysiology)

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Lipid Research

  • ISSN

    0022-2275

  • e-ISSN

  • Volume of the periodical

    58

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    9

  • Pages from-to

    403-411

  • UT code for WoS article

    000395108900010

  • EID of the result in the Scopus database

    2-s2.0-85011284377